BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Cyclacel Pharmaceuticals, Inc. ("Cyclacel", the "Company") (Nasdaq: CYCC) (Nasdaq: CYCCP) announced today that the Company's Board of Directors has declared a quarterly dividend in the amount of $0.15 per share on its 6% Convertible Exchangeable Preferred Stock (the "Preferred Stock") in accordance with the terms thereof. Cyclacel issued 2,990,000 shares of the Preferred Stock in November 2004. As of January 30, 2007 approximately 943,000 shares of the Preferred Stock had been converted to the Company's common stock. The dividend on the Preferred Stock will be paid on February 1, 2007 to the holders of record as of the close of business on January 22, 2007.
